Catherine Reed

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. pmc Health care costs before and after diagnosis of depression in patients with unexplained pain: a retrospective cohort study using the United Kingdom General Practice Research Database
    Catherine Reed
    Global Health Outcomes, Eli Lilly and Company, Windlesham, Surrey, UK
    Clinicoecon Outcomes Res 5:37-47. 2013
  2. pmc Mixed states vs. pure mania in the French sample of the EMBLEM study: results at baseline and 24 months--European mania in bipolar longitudinal evaluation of medication
    Jean Michel Azorin
    Neurosciences Medical department, Eli Lilly and Company, Suresnes, France
    BMC Psychiatry 9:33. 2009
  3. doi request reprint Quality of life outcomes among patients with depression after 6 months of starting treatment: results from FINDER
    Catherine Reed
    Eli Lilly and Company Ltd, Erl Wood Manor, Windlesham, Surrey, UK
    J Affect Disord 113:296-302. 2009
  4. doi request reprint Work impairment in bipolar disorder patients--results from a two-year observational study (EMBLEM)
    C Reed
    Eli Lilly and Company Limited, Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, Windlesham GU20 6PH, UK
    Eur Psychiatry 25:338-44. 2010
  5. doi request reprint Observational study designs for bipolar disorder - what can they tell us about treatment in acute mania?
    Catherine Reed
    Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, GU20 6PH, UK
    Prog Neuropsychopharmacol Biol Psychiatry 33:715-21. 2009
  6. doi request reprint Comparison of olanzapine and risperidone in the EMBLEM Study: translation of randomized controlled trial findings into clinical practice
    Diego Novick
    Lilly Research Centre, Windlesham, Surrey, UK
    Int Clin Psychopharmacol 25:257-63. 2010
  7. doi request reprint Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis
    Inge van Rossum
    Medical Department, Eli Lilly Nederland, Houten, The Netherlands
    J Nerv Ment Dis 197:35-40. 2009
  8. doi request reprint Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) study
    Jihyung Hong
    Personal Social Services Research Unit, London School of Economics, London, UK
    Psychiatry Res 190:110-4. 2011
  9. doi request reprint Costs associated with treatment of chronic low back pain: an analysis of the UK General Practice Research Database
    Jihyung Hong
    Personal Social Services Research Unit, London School of Economics and Political Science, London, United Kingdom
    Spine (Phila Pa 1976) 38:75-82. 2013

Detail Information

Publications10

  1. pmc Health care costs before and after diagnosis of depression in patients with unexplained pain: a retrospective cohort study using the United Kingdom General Practice Research Database
    Catherine Reed
    Global Health Outcomes, Eli Lilly and Company, Windlesham, Surrey, UK
    Clinicoecon Outcomes Res 5:37-47. 2013
    ..To assess the impact of pain severity and time to diagnosis of depression on health care costs for primary care patients with pre-existing unexplained pain symptoms who subsequently received a diagnosis of depression...
  2. pmc Mixed states vs. pure mania in the French sample of the EMBLEM study: results at baseline and 24 months--European mania in bipolar longitudinal evaluation of medication
    Jean Michel Azorin
    Neurosciences Medical department, Eli Lilly and Company, Suresnes, France
    BMC Psychiatry 9:33. 2009
    ..To describe the clinical course and treatment patterns over 24 months of patients experiencing an acute manic/mixed episode within the standard course of care...
  3. doi request reprint Quality of life outcomes among patients with depression after 6 months of starting treatment: results from FINDER
    Catherine Reed
    Eli Lilly and Company Ltd, Erl Wood Manor, Windlesham, Surrey, UK
    J Affect Disord 113:296-302. 2009
    ..We studied the impact of antidepressant (AD) treatment on HRQoL outcomes in depressed patients and investigated factors associated with these outcomes in routine practice settings...
  4. doi request reprint Work impairment in bipolar disorder patients--results from a two-year observational study (EMBLEM)
    C Reed
    Eli Lilly and Company Limited, Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, Windlesham GU20 6PH, UK
    Eur Psychiatry 25:338-44. 2010
    ..To explore factors associated with work impairment at 2 years following an acute episode...
  5. doi request reprint Observational study designs for bipolar disorder - what can they tell us about treatment in acute mania?
    Catherine Reed
    Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, GU20 6PH, UK
    Prog Neuropsychopharmacol Biol Psychiatry 33:715-21. 2009
    ..4%) and week 12 (50.5%). The results of this observational study show that treatment for mania is complex with multiple combinations of treatment and frequent switching during an acute episode...
  6. doi request reprint Comparison of olanzapine and risperidone in the EMBLEM Study: translation of randomized controlled trial findings into clinical practice
    Diego Novick
    Lilly Research Centre, Windlesham, Surrey, UK
    Int Clin Psychopharmacol 25:257-63. 2010
    ..Limitations include differences in study design, patient population, and length of follow-up...
  7. doi request reprint Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis
    Inge van Rossum
    Medical Department, Eli Lilly Nederland, Houten, The Netherlands
    J Nerv Ment Dis 197:35-40. 2009
    ..An independent impact of cannabis use on psychopathologic outcomes in patients with bipolar disorder was apparent, whereas the impact on social outcomes was modest...
  8. doi request reprint Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) study
    Jihyung Hong
    Personal Social Services Research Unit, London School of Economics, London, UK
    Psychiatry Res 190:110-4. 2011
    ..05). In conclusion, non-adherence in bipolar patients was associated with poorer long term clinical outcomes that have economic implications for health-care providers...
  9. doi request reprint Costs associated with treatment of chronic low back pain: an analysis of the UK General Practice Research Database
    Jihyung Hong
    Personal Social Services Research Unit, London School of Economics and Political Science, London, United Kingdom
    Spine (Phila Pa 1976) 38:75-82. 2013
    ..Retrospective cohort study of health care costs associated with the treatment of chronic low back pain (CLBP) in the United Kingdom...